A864

Classifies xylazine as a Schedule III controlled dangerous substance in New Jersey, except for veterinary use.

This bill classifies xylazine as a Schedule III controlled dangerous substance in New Jersey, except when it is acquired, prescribed, administered, or dispensed by a veterinarian in the course of professional veterinary practice. Xylazine, known on the street as “tranq,” “tranq dope,” and “zombie drug,” is an animal sedative that has not been approved for human use. It is often mixed with opioids, enhancing their effects but also increasing the risk of overdose and severe health issues.